Izumiyama, Koh, Tasuku Inao, Hideki Goto, Shinpei Harada, Hajime Senjo, Keito Suto, Junichi Hashiguchi, Reiki Ogasawara, Tomoyuki Saga, Tetsuyuki Igarashi, Kentaro Wakasa, Ikumi Kasahara, Yukari Takeda, Keisuke Yamaguchi, Akio Shigematsu, Mutsumi Takahata, Katsuya Fujimoto, Yoshihito Haseyama, Takahiro Nagashima, Hajime Sakai, Yasutaka Kakinoki, Mitsutoshi Kurosawa, Isao Yokota, and Takanori Teshima. 2020. “Event-Free Survival at 36 Months Is a Suitable Endpoint for Diffuse Large B-Cell Lymphoma Patients Treated With Immunochemotherapy: Real-World Evidence from the North Japan Hematology Study Group”. Haematologica, September. Pavia, Italy. https://doi.org/10.3324/haematol.2023.284841.